Home ProductsPharmaceutical Intermediates

Sex Enhancement Flibanserin women Pharmaceutical Intermediates for Sexual Desire Disorder

Certification
China Hengyang Desen Biotechnology Co., Ltd. certification
China Hengyang Desen Biotechnology Co., Ltd. certification
Customer Reviews
Awesome, thanks Irina. You've actually been the fastest and most responsive so far, you're going to be getting a lottt of business from me in future.

—— Andressa Hernandez from Brazil

EllenCaisin! I test the product, it is so good! Very happy. and I gave the treats to my family, you might be the best I ever used. best service!!!

—— Gabriel Collin from Canada

Aaron Fantastic! I have received the package. Thank you very much for great packaging. If it is good quality, you must have me as a long time customer

—— Mitch Kelly from USA

Yep Koala! got package thankyou so much, Koala. I like to place another order now. how much is T3 and tren a

—— Joaquin Vega from Spain

I'm Online Chat Now

Sex Enhancement Flibanserin women Pharmaceutical Intermediates for Sexual Desire Disorder

large.img.alt
small.img.alt small.img.alt small.img.alt

Large Image :  Sex Enhancement Flibanserin women Pharmaceutical Intermediates for Sexual Desire Disorder

Product Details:
Place of Origin: China
Brand Name: ChineseHormone
Certification: GMP, ISO 9001, USP
Model Number: CAS 167933-07-5
Payment & Shipping Terms:
Minimum Order Quantity: Free samples Available
Price: negotiated
Packaging Details: as your required
Delivery Time: 3-6 working days
Payment Terms: Western Union, MoneyGram, T/T, Bitcoin
Supply Ability: 500-1000 kg / month
Detailed Product Description
MW: 390.40 Alias: Addyi
Appearance: White Crystalline Powder MF: C20H21F3N4O
Shipment:: FedEx, TNT, EMS, DHL.UPS,EUB Usage: Hypoactive Sexual Desire Disorder (HSDD)
High Light:

pharmaceutical raw material

,

raw pharmaceutical materials

 

Female Sex Enhancement  Flibanserin for Sexual Desire Disorder 

 

Flibanserin, sold under the trade name Addyi, is a medication approved for the treatment of pre-menopausal women with hypoactive sexual desire disorder (HSDD). The medication increases the number of satisfying sexual events per month by about one half over placebo from a starting point of about two to three. 

 

The certainty of the estimate is low. The side effects of dizziness, sleepiness, and nauseaoccur about three to four times more often.Development by Boehringer Ingelheim was halted in October 2010 following a negative evaluation by the U.S. 

 

HSDD was recognized as a distinct sexual function disorder for more than 30 years, but was removed from theDiagnostic and Statistical Manual of Mental Disorders in 2013, and replaced with a new diagnosis calledfemale sexual interest/arousal disorder (FSIAD).

 

Sex Enhancement Flibanserin women Pharmaceutical Intermediates for Sexual Desire Disorder 0

 

Mechanism of action

 

Flibansetrin has high affinity for serotonin receptors in the brain: it acts as an agonist on 5-HT1A and an antagonist on 5-HT2A. In vivo, flibanserin binds equally to 5-HT1A and 5-HT2A receptors. However, under higher levels of brain 5-HT (i.e., under stress), flibanserin may occupy 5-HT2A receptors in higher proportion than 5-HT(1A) receptors.

 

It may also moderately antagonize D4 (dopamine) receptors and 5-HT2B and 5-HTB2C. Its action on neurotransmitter receptors may contribute to reduction in serotonin levels and increase in dopamine and norepinephrine levels, all of which may play part in reward processing.

 

Property Value
Water Solubility 0.178 mg/mL
pKa (Strongest Acidic) 12.91
pKa (Strongest Basic) 7.03
Polar Surface Area 38.82 Å2
Refractivity 103.65 m3·mol-1
Polarizability 38.69 Å3

 

 

Sex Enhancement Flibanserin women Pharmaceutical Intermediates for Sexual Desire Disorder 1

 

Contact Details
Hengyang Desen Biotechnology Co., Ltd.

Contact Person: Sales Manager

Send your inquiry directly to us (0 / 3000)